Regulatory PathRegulatory requirements compared

Active substances

Acetylsalicylic acid + Ascorbic acid

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
ASPIRIN EFFERVESCENT WITH VITAMIN C400,240 mg,mgEffervescent tablet · Oral use10 Tablet ContainerSAR 8.15NCE · OTCBAYER CONSUMER CARE AGValid
ASPIRIN EFFERVESCENT WITH VITAMIN C400, 240 mgEffervescent tablet · Oral use10 Tablet ContainerSAR 8.15NCE · OTCBAYER PHARMA AGWithdrawn by MAH · Not Marketed
SEDERGINE Effervescent tablet330,200 mg,mgEffervescent tablet · Oral use20 BlisterSAR 4.80NCE · OTCUPSAWithdrawn by MAH · Not Marketed
Indications — CHI Daman Drug Formulary

BELL'S PALSY; MIGRAINE/ HEADACHE

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.